nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—CYP2C19—epilepsy syndrome	0.102	0.48	CbGaD
Losartan—UGT1A10—Valproic Acid—epilepsy syndrome	0.0576	0.109	CbGbCtD
Losartan—ALB—epilepsy syndrome	0.0564	0.266	CbGaD
Losartan—ABCB1—epilepsy syndrome	0.0538	0.254	CbGaD
Losartan—UGT1A3—Lamotrigine—epilepsy syndrome	0.037	0.0697	CbGbCtD
Losartan—UGT2B7—Carbamazepine—epilepsy syndrome	0.023	0.0434	CbGbCtD
Losartan—UGT1A3—Valproic Acid—epilepsy syndrome	0.019	0.0358	CbGbCtD
Losartan—UGT1A1—Propofol—epilepsy syndrome	0.0166	0.0314	CbGbCtD
Losartan—UGT2B7—Valproic Acid—epilepsy syndrome	0.0137	0.0259	CbGbCtD
Losartan—ALB—Oxcarbazepine—epilepsy syndrome	0.012	0.0226	CbGbCtD
Losartan—ALB—Fosphenytoin—epilepsy syndrome	0.0105	0.0198	CbGbCtD
Losartan—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00965	0.0182	CbGbCtD
Losartan—ALB—Clonazepam—epilepsy syndrome	0.00949	0.0179	CbGbCtD
Losartan—CYP2C8—Trimethadione—epilepsy syndrome	0.00863	0.0163	CbGbCtD
Losartan—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00811	0.0153	CbGbCtD
Losartan—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00778	0.0147	CbGbCtD
Losartan—ALB—Rufinamide—epilepsy syndrome	0.00774	0.0146	CbGbCtD
Losartan—CYP2C19—Trimethadione—epilepsy syndrome	0.00724	0.0136	CbGbCtD
Losartan—CYP2C19—Felbamate—epilepsy syndrome	0.00724	0.0136	CbGbCtD
Losartan—SLC22A6—Acetazolamide—epilepsy syndrome	0.00708	0.0133	CbGbCtD
Losartan—ABCB1—Levetiracetam—epilepsy syndrome	0.00687	0.0129	CbGbCtD
Losartan—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0068	0.0128	CbGbCtD
Losartan—ALB—Phenytoin—epilepsy syndrome	0.00676	0.0127	CbGbCtD
Losartan—ALB—Propofol—epilepsy syndrome	0.00631	0.0119	CbGbCtD
Losartan—CYP3A5—Carbamazepine—epilepsy syndrome	0.00606	0.0114	CbGbCtD
Losartan—CYP2C9—Trimethadione—epilepsy syndrome	0.00602	0.0113	CbGbCtD
Losartan—CYP2C19—Clobazam—epilepsy syndrome	0.0059	0.0111	CbGbCtD
Losartan—CYP2C8—Carbamazepine—epilepsy syndrome	0.00583	0.011	CbGbCtD
Losartan—ALB—Diazepam—epilepsy syndrome	0.00571	0.0108	CbGbCtD
Losartan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00566	0.0107	CbGbCtD
Losartan—CYP2C8—Primidone—epilepsy syndrome	0.00544	0.0103	CbGbCtD
Losartan—CYP3A5—Phenytoin—epilepsy syndrome	0.00544	0.0102	CbGbCtD
Losartan—SLC22A6—Valproic Acid—epilepsy syndrome	0.00529	0.00997	CbGbCtD
Losartan—CYP2C8—Phenytoin—epilepsy syndrome	0.00523	0.00985	CbGbCtD
Losartan—CYP2C19—Carbamazepine—epilepsy syndrome	0.00489	0.00921	CbGbCtD
Losartan—CYP2C8—Propofol—epilepsy syndrome	0.00487	0.00919	CbGbCtD
Losartan—CYP3A5—Phenobarbital—epilepsy syndrome	0.00485	0.00913	CbGbCtD
Losartan—CYP3A5—Midazolam—epilepsy syndrome	0.00478	0.00901	CbGbCtD
Losartan—ABCB1—Clobazam—epilepsy syndrome	0.00476	0.00897	CbGbCtD
Losartan—CYP2C8—Phenobarbital—epilepsy syndrome	0.00466	0.00878	CbGbCtD
Losartan—CYP3A5—Diazepam—epilepsy syndrome	0.00459	0.00866	CbGbCtD
Losartan—ABCB1—Lamotrigine—epilepsy syndrome	0.00458	0.00864	CbGbCtD
Losartan—CYP2C19—Primidone—epilepsy syndrome	0.00456	0.0086	CbGbCtD
Losartan—CYP1A2—Carbamazepine—epilepsy syndrome	0.00451	0.0085	CbGbCtD
Losartan—CYP2C8—Diazepam—epilepsy syndrome	0.00442	0.00832	CbGbCtD
Losartan—CYP2C19—Phenytoin—epilepsy syndrome	0.00438	0.00827	CbGbCtD
Losartan—CYP1A2—Primidone—epilepsy syndrome	0.00421	0.00794	CbGbCtD
Losartan—CYP2C19—Propofol—epilepsy syndrome	0.00409	0.00771	CbGbCtD
Losartan—CYP2C9—Carbamazepine—epilepsy syndrome	0.00406	0.00766	CbGbCtD
Losartan—ABCB1—Carbamazepine—epilepsy syndrome	0.00394	0.00744	CbGbCtD
Losartan—CYP2C19—Phenobarbital—epilepsy syndrome	0.00391	0.00737	CbGbCtD
Losartan—CYP2C9—Primidone—epilepsy syndrome	0.00379	0.00715	CbGbCtD
Losartan—CYP1A2—Propofol—epilepsy syndrome	0.00377	0.00711	CbGbCtD
Losartan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00376	0.00709	CbGbCtD
Losartan—CYP2C19—Diazepam—epilepsy syndrome	0.0037	0.00698	CbGbCtD
Losartan—CYP2C9—Phenytoin—epilepsy syndrome	0.00365	0.00687	CbGbCtD
Losartan—CYP3A5—Valproic Acid—epilepsy syndrome	0.00362	0.00682	CbGbCtD
Losartan—CYP2C19—Zonisamide—epilepsy syndrome	0.00362	0.00682	CbGbCtD
Losartan—CYP1A2—Phenobarbital—epilepsy syndrome	0.00361	0.0068	CbGbCtD
Losartan—ABCB1—Phenytoin—epilepsy syndrome	0.00354	0.00667	CbGbCtD
Losartan—CYP3A4—Felbamate—epilepsy syndrome	0.0035	0.00659	CbGbCtD
Losartan—CYP3A4—Trimethadione—epilepsy syndrome	0.0035	0.00659	CbGbCtD
Losartan—CYP2C8—Valproic Acid—epilepsy syndrome	0.00348	0.00656	CbGbCtD
Losartan—CYP1A2—Diazepam—epilepsy syndrome	0.00342	0.00644	CbGbCtD
Losartan—CYP2C9—Propofol—epilepsy syndrome	0.0034	0.00641	CbGbCtD
Losartan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00329	0.0062	CbGbCtD
Losartan—CYP2C9—Phenobarbital—epilepsy syndrome	0.00325	0.00612	CbGbCtD
Losartan—ABCB1—Phenobarbital—epilepsy syndrome	0.00315	0.00594	CbGbCtD
Losartan—ABCB1—Midazolam—epilepsy syndrome	0.00311	0.00586	CbGbCtD
Losartan—CYP2C9—Diazepam—epilepsy syndrome	0.00308	0.00581	CbGbCtD
Losartan—ABCB1—Diazepam—epilepsy syndrome	0.00299	0.00563	CbGbCtD
Losartan—CYP3A4—Clonazepam—epilepsy syndrome	0.00297	0.00561	CbGbCtD
Losartan—CYP2C19—Valproic Acid—epilepsy syndrome	0.00292	0.00551	CbGbCtD
Losartan—CYP3A4—Clobazam—epilepsy syndrome	0.00285	0.00538	CbGbCtD
Losartan—CYP1A2—Valproic Acid—epilepsy syndrome	0.00269	0.00508	CbGbCtD
Losartan—CYP2C19—Topiramate—epilepsy syndrome	0.00264	0.00497	CbGbCtD
Losartan—CYP2C9—Valproic Acid—epilepsy syndrome	0.00243	0.00458	CbGbCtD
Losartan—CYP3A4—Rufinamide—epilepsy syndrome	0.00243	0.00457	CbGbCtD
Losartan—CYP3A4—Carbamazepine—epilepsy syndrome	0.00236	0.00445	CbGbCtD
Losartan—CYP3A4—Primidone—epilepsy syndrome	0.00221	0.00416	CbGbCtD
Losartan—CYP3A4—Phenytoin—epilepsy syndrome	0.00212	0.004	CbGbCtD
Losartan—CYP3A4—Propofol—epilepsy syndrome	0.00198	0.00373	CbGbCtD
Losartan—CYP3A4—Phenobarbital—epilepsy syndrome	0.00189	0.00356	CbGbCtD
Losartan—CYP3A4—Acetazolamide—epilepsy syndrome	0.00189	0.00356	CbGbCtD
Losartan—CYP3A4—Midazolam—epilepsy syndrome	0.00186	0.00351	CbGbCtD
Losartan—CYP3A4—Diazepam—epilepsy syndrome	0.00179	0.00338	CbGbCtD
Losartan—CYP3A4—Zonisamide—epilepsy syndrome	0.00175	0.0033	CbGbCtD
Losartan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00141	0.00266	CbGbCtD
Losartan—CYP3A4—Topiramate—epilepsy syndrome	0.00127	0.0024	CbGbCtD
Losartan—Eprosartan—ABCC2—epilepsy syndrome	0.000797	0.27	CrCbGaD
Losartan—Irbesartan—JUN—epilepsy syndrome	0.000631	0.214	CrCbGaD
Losartan—Olmesartan—ABCC2—epilepsy syndrome	0.000309	0.105	CrCbGaD
Losartan—Telmisartan—ABCC2—epilepsy syndrome	0.000298	0.101	CrCbGaD
Losartan—Telmisartan—ABCG2—epilepsy syndrome	0.000264	0.0893	CrCbGaD
Losartan—Telmisartan—CYP2C19—epilepsy syndrome	0.000207	0.0702	CrCbGaD
Losartan—Irbesartan—CYP2D6—epilepsy syndrome	0.000124	0.042	CrCbGaD
Losartan—Valsartan—ALB—epilepsy syndrome	0.000122	0.0414	CrCbGaD
Losartan—Telmisartan—ABCB1—epilepsy syndrome	0.00011	0.0372	CrCbGaD
Losartan—Candesartan—ABCB1—epilepsy syndrome	8.85e-05	0.03	CrCbGaD
Losartan—Dermatitis—Vigabatrin—epilepsy syndrome	4.11e-05	0.000248	CcSEcCtD
Losartan—Pruritus—Oxcarbazepine—epilepsy syndrome	4.1e-05	0.000247	CcSEcCtD
Losartan—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.1e-05	0.000247	CcSEcCtD
Losartan—Vision blurred—Gabapentin—epilepsy syndrome	4.09e-05	0.000246	CcSEcCtD
Losartan—Headache—Vigabatrin—epilepsy syndrome	4.09e-05	0.000246	CcSEcCtD
Losartan—Vomiting—Diazepam—epilepsy syndrome	4.09e-05	0.000246	CcSEcCtD
Losartan—Anorexia—Valproic Acid—epilepsy syndrome	4.07e-05	0.000245	CcSEcCtD
Losartan—Tremor—Gabapentin—epilepsy syndrome	4.07e-05	0.000245	CcSEcCtD
Losartan—Rash—Diazepam—epilepsy syndrome	4.05e-05	0.000244	CcSEcCtD
Losartan—Dermatitis—Diazepam—epilepsy syndrome	4.05e-05	0.000244	CcSEcCtD
Losartan—Chest pain—Pregabalin—epilepsy syndrome	4.03e-05	0.000243	CcSEcCtD
Losartan—Arthralgia—Pregabalin—epilepsy syndrome	4.03e-05	0.000243	CcSEcCtD
Losartan—Myalgia—Pregabalin—epilepsy syndrome	4.03e-05	0.000243	CcSEcCtD
Losartan—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.03e-05	0.000242	CcSEcCtD
Losartan—Dizziness—Zonisamide—epilepsy syndrome	4.03e-05	0.000242	CcSEcCtD
Losartan—Headache—Diazepam—epilepsy syndrome	4.03e-05	0.000242	CcSEcCtD
Losartan—Anxiety—Pregabalin—epilepsy syndrome	4.02e-05	0.000242	CcSEcCtD
Losartan—Diarrhoea—Clonazepam—epilepsy syndrome	4.02e-05	0.000242	CcSEcCtD
Losartan—Anaemia—Gabapentin—epilepsy syndrome	4.01e-05	0.000241	CcSEcCtD
Losartan—Hypotension—Valproic Acid—epilepsy syndrome	3.99e-05	0.00024	CcSEcCtD
Losartan—Asthenia—Carbamazepine—epilepsy syndrome	3.99e-05	0.00024	CcSEcCtD
Losartan—Agitation—Gabapentin—epilepsy syndrome	3.99e-05	0.00024	CcSEcCtD
Losartan—Diarrhoea—Phenytoin—epilepsy syndrome	3.99e-05	0.00024	CcSEcCtD
Losartan—Discomfort—Pregabalin—epilepsy syndrome	3.98e-05	0.00024	CcSEcCtD
Losartan—Nausea—Fosphenytoin—epilepsy syndrome	3.98e-05	0.000239	CcSEcCtD
Losartan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000239	CcSEcCtD
Losartan—Erythema multiforme—Topiramate—epilepsy syndrome	3.97e-05	0.000239	CcSEcCtD
Losartan—Angioedema—Gabapentin—epilepsy syndrome	3.97e-05	0.000239	CcSEcCtD
Losartan—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.96e-05	0.000238	CcSEcCtD
Losartan—Vomiting—Felbamate—epilepsy syndrome	3.96e-05	0.000238	CcSEcCtD
Losartan—Dry mouth—Pregabalin—epilepsy syndrome	3.94e-05	0.000237	CcSEcCtD
Losartan—Pruritus—Carbamazepine—epilepsy syndrome	3.94e-05	0.000237	CcSEcCtD
Losartan—Rash—Felbamate—epilepsy syndrome	3.92e-05	0.000236	CcSEcCtD
Losartan—Dermatitis—Felbamate—epilepsy syndrome	3.92e-05	0.000236	CcSEcCtD
Losartan—Malaise—Gabapentin—epilepsy syndrome	3.92e-05	0.000236	CcSEcCtD
Losartan—Tinnitus—Topiramate—epilepsy syndrome	3.91e-05	0.000235	CcSEcCtD
Losartan—Vertigo—Gabapentin—epilepsy syndrome	3.9e-05	0.000235	CcSEcCtD
Losartan—Headache—Felbamate—epilepsy syndrome	3.9e-05	0.000235	CcSEcCtD
Losartan—Confusional state—Pregabalin—epilepsy syndrome	3.9e-05	0.000234	CcSEcCtD
Losartan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.89e-05	0.000234	CcSEcCtD
Losartan—Flushing—Topiramate—epilepsy syndrome	3.89e-05	0.000234	CcSEcCtD
Losartan—Syncope—Gabapentin—epilepsy syndrome	3.89e-05	0.000234	CcSEcCtD
Losartan—Leukopenia—Gabapentin—epilepsy syndrome	3.89e-05	0.000234	CcSEcCtD
Losartan—Dizziness—Clonazepam—epilepsy syndrome	3.88e-05	0.000234	CcSEcCtD
Losartan—Nausea—Vigabatrin—epilepsy syndrome	3.88e-05	0.000233	CcSEcCtD
Losartan—Vomiting—Zonisamide—epilepsy syndrome	3.87e-05	0.000233	CcSEcCtD
Losartan—Insomnia—Valproic Acid—epilepsy syndrome	3.87e-05	0.000233	CcSEcCtD
Losartan—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.86e-05	0.000233	CcSEcCtD
Losartan—Oedema—Pregabalin—epilepsy syndrome	3.86e-05	0.000233	CcSEcCtD
Losartan—Asthenia—Lamotrigine—epilepsy syndrome	3.86e-05	0.000232	CcSEcCtD
Losartan—Dizziness—Phenytoin—epilepsy syndrome	3.86e-05	0.000232	CcSEcCtD
Losartan—Rash—Zonisamide—epilepsy syndrome	3.84e-05	0.000231	CcSEcCtD
Losartan—Infection—Pregabalin—epilepsy syndrome	3.84e-05	0.000231	CcSEcCtD
Losartan—Paraesthesia—Valproic Acid—epilepsy syndrome	3.84e-05	0.000231	CcSEcCtD
Losartan—Palpitations—Gabapentin—epilepsy syndrome	3.84e-05	0.000231	CcSEcCtD
Losartan—Dermatitis—Zonisamide—epilepsy syndrome	3.84e-05	0.000231	CcSEcCtD
Losartan—Dizziness—Oxcarbazepine—epilepsy syndrome	3.84e-05	0.000231	CcSEcCtD
Losartan—Nausea—Diazepam—epilepsy syndrome	3.82e-05	0.00023	CcSEcCtD
Losartan—Loss of consciousness—Gabapentin—epilepsy syndrome	3.82e-05	0.00023	CcSEcCtD
Losartan—Headache—Zonisamide—epilepsy syndrome	3.82e-05	0.00023	CcSEcCtD
Losartan—Dyspnoea—Valproic Acid—epilepsy syndrome	3.81e-05	0.000229	CcSEcCtD
Losartan—Diarrhoea—Carbamazepine—epilepsy syndrome	3.81e-05	0.000229	CcSEcCtD
Losartan—Angiopathy—Topiramate—epilepsy syndrome	3.81e-05	0.000229	CcSEcCtD
Losartan—Pruritus—Lamotrigine—epilepsy syndrome	3.81e-05	0.000229	CcSEcCtD
Losartan—Shock—Pregabalin—epilepsy syndrome	3.8e-05	0.000229	CcSEcCtD
Losartan—Somnolence—Valproic Acid—epilepsy syndrome	3.8e-05	0.000229	CcSEcCtD
Losartan—Nervous system disorder—Pregabalin—epilepsy syndrome	3.79e-05	0.000228	CcSEcCtD
Losartan—Cough—Gabapentin—epilepsy syndrome	3.79e-05	0.000228	CcSEcCtD
Losartan—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.78e-05	0.000228	CcSEcCtD
Losartan—Tachycardia—Pregabalin—epilepsy syndrome	3.77e-05	0.000227	CcSEcCtD
Losartan—Dyspepsia—Valproic Acid—epilepsy syndrome	3.76e-05	0.000226	CcSEcCtD
Losartan—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.74e-05	0.000225	CcSEcCtD
Losartan—Vomiting—Clonazepam—epilepsy syndrome	3.73e-05	0.000225	CcSEcCtD
Losartan—Decreased appetite—Valproic Acid—epilepsy syndrome	3.72e-05	0.000224	CcSEcCtD
Losartan—Alopecia—Topiramate—epilepsy syndrome	3.71e-05	0.000223	CcSEcCtD
Losartan—Vomiting—Phenytoin—epilepsy syndrome	3.71e-05	0.000223	CcSEcCtD
Losartan—Rash—Clonazepam—epilepsy syndrome	3.7e-05	0.000223	CcSEcCtD
Losartan—Dermatitis—Clonazepam—epilepsy syndrome	3.7e-05	0.000222	CcSEcCtD
Losartan—Myalgia—Gabapentin—epilepsy syndrome	3.7e-05	0.000222	CcSEcCtD
Losartan—Chest pain—Gabapentin—epilepsy syndrome	3.7e-05	0.000222	CcSEcCtD
Losartan—Arthralgia—Gabapentin—epilepsy syndrome	3.7e-05	0.000222	CcSEcCtD
Losartan—Nausea—Felbamate—epilepsy syndrome	3.7e-05	0.000222	CcSEcCtD
Losartan—Vomiting—Oxcarbazepine—epilepsy syndrome	3.69e-05	0.000222	CcSEcCtD
Losartan—Fatigue—Valproic Acid—epilepsy syndrome	3.69e-05	0.000222	CcSEcCtD
Losartan—Anxiety—Gabapentin—epilepsy syndrome	3.68e-05	0.000222	CcSEcCtD
Losartan—Anorexia—Pregabalin—epilepsy syndrome	3.68e-05	0.000222	CcSEcCtD
Losartan—Dizziness—Carbamazepine—epilepsy syndrome	3.68e-05	0.000221	CcSEcCtD
Losartan—Diarrhoea—Lamotrigine—epilepsy syndrome	3.68e-05	0.000221	CcSEcCtD
Losartan—Headache—Clonazepam—epilepsy syndrome	3.68e-05	0.000221	CcSEcCtD
Losartan—Rash—Phenytoin—epilepsy syndrome	3.68e-05	0.000221	CcSEcCtD
Losartan—Dermatitis—Phenytoin—epilepsy syndrome	3.67e-05	0.000221	CcSEcCtD
Losartan—Rash—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.00022	CcSEcCtD
Losartan—Pain—Valproic Acid—epilepsy syndrome	3.66e-05	0.00022	CcSEcCtD
Losartan—Constipation—Valproic Acid—epilepsy syndrome	3.66e-05	0.00022	CcSEcCtD
Losartan—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.65e-05	0.00022	CcSEcCtD
Losartan—Headache—Phenytoin—epilepsy syndrome	3.65e-05	0.00022	CcSEcCtD
Losartan—Erythema—Topiramate—epilepsy syndrome	3.65e-05	0.00022	CcSEcCtD
Losartan—Discomfort—Gabapentin—epilepsy syndrome	3.65e-05	0.00022	CcSEcCtD
Losartan—Headache—Oxcarbazepine—epilepsy syndrome	3.63e-05	0.000219	CcSEcCtD
Losartan—Nausea—Zonisamide—epilepsy syndrome	3.62e-05	0.000218	CcSEcCtD
Losartan—Dry mouth—Gabapentin—epilepsy syndrome	3.62e-05	0.000218	CcSEcCtD
Losartan—Hypotension—Pregabalin—epilepsy syndrome	3.61e-05	0.000217	CcSEcCtD
Losartan—Flatulence—Topiramate—epilepsy syndrome	3.6e-05	0.000217	CcSEcCtD
Losartan—Tension—Topiramate—epilepsy syndrome	3.58e-05	0.000216	CcSEcCtD
Losartan—Dysgeusia—Topiramate—epilepsy syndrome	3.58e-05	0.000215	CcSEcCtD
Losartan—Confusional state—Gabapentin—epilepsy syndrome	3.57e-05	0.000215	CcSEcCtD
Losartan—Dizziness—Lamotrigine—epilepsy syndrome	3.56e-05	0.000214	CcSEcCtD
Losartan—Nervousness—Topiramate—epilepsy syndrome	3.55e-05	0.000213	CcSEcCtD
Losartan—Oedema—Gabapentin—epilepsy syndrome	3.54e-05	0.000213	CcSEcCtD
Losartan—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.54e-05	0.000213	CcSEcCtD
Losartan—Vomiting—Carbamazepine—epilepsy syndrome	3.54e-05	0.000213	CcSEcCtD
Losartan—Back pain—Topiramate—epilepsy syndrome	3.53e-05	0.000213	CcSEcCtD
Losartan—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.52e-05	0.000212	CcSEcCtD
Losartan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.52e-05	0.000212	CcSEcCtD
Losartan—Infection—Gabapentin—epilepsy syndrome	3.52e-05	0.000212	CcSEcCtD
Losartan—Muscle spasms—Topiramate—epilepsy syndrome	3.51e-05	0.000211	CcSEcCtD
Losartan—Rash—Carbamazepine—epilepsy syndrome	3.51e-05	0.000211	CcSEcCtD
Losartan—Dermatitis—Carbamazepine—epilepsy syndrome	3.51e-05	0.000211	CcSEcCtD
Losartan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.5e-05	0.00021	CcSEcCtD
Losartan—Insomnia—Pregabalin—epilepsy syndrome	3.5e-05	0.00021	CcSEcCtD
Losartan—Nausea—Clonazepam—epilepsy syndrome	3.49e-05	0.00021	CcSEcCtD
Losartan—Headache—Carbamazepine—epilepsy syndrome	3.49e-05	0.00021	CcSEcCtD
Losartan—Shock—Gabapentin—epilepsy syndrome	3.49e-05	0.00021	CcSEcCtD
Losartan—Nervous system disorder—Gabapentin—epilepsy syndrome	3.48e-05	0.000209	CcSEcCtD
Losartan—Paraesthesia—Pregabalin—epilepsy syndrome	3.47e-05	0.000209	CcSEcCtD
Losartan—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.47e-05	0.000209	CcSEcCtD
Losartan—Nausea—Phenytoin—epilepsy syndrome	3.46e-05	0.000208	CcSEcCtD
Losartan—Tachycardia—Gabapentin—epilepsy syndrome	3.46e-05	0.000208	CcSEcCtD
Losartan—Dyspnoea—Pregabalin—epilepsy syndrome	3.45e-05	0.000207	CcSEcCtD
Losartan—Nausea—Oxcarbazepine—epilepsy syndrome	3.45e-05	0.000207	CcSEcCtD
Losartan—Vision blurred—Topiramate—epilepsy syndrome	3.44e-05	0.000207	CcSEcCtD
Losartan—Somnolence—Pregabalin—epilepsy syndrome	3.44e-05	0.000207	CcSEcCtD
Losartan—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.43e-05	0.000206	CcSEcCtD
Losartan—Tremor—Topiramate—epilepsy syndrome	3.42e-05	0.000206	CcSEcCtD
Losartan—Vomiting—Lamotrigine—epilepsy syndrome	3.42e-05	0.000206	CcSEcCtD
Losartan—Urticaria—Valproic Acid—epilepsy syndrome	3.4e-05	0.000204	CcSEcCtD
Losartan—Rash—Lamotrigine—epilepsy syndrome	3.39e-05	0.000204	CcSEcCtD
Losartan—Ill-defined disorder—Topiramate—epilepsy syndrome	3.39e-05	0.000204	CcSEcCtD
Losartan—Dermatitis—Lamotrigine—epilepsy syndrome	3.39e-05	0.000204	CcSEcCtD
Losartan—Body temperature increased—Valproic Acid—epilepsy syndrome	3.38e-05	0.000203	CcSEcCtD
Losartan—Abdominal pain—Valproic Acid—epilepsy syndrome	3.38e-05	0.000203	CcSEcCtD
Losartan—Anorexia—Gabapentin—epilepsy syndrome	3.38e-05	0.000203	CcSEcCtD
Losartan—Anaemia—Topiramate—epilepsy syndrome	3.38e-05	0.000203	CcSEcCtD
Losartan—Headache—Lamotrigine—epilepsy syndrome	3.37e-05	0.000203	CcSEcCtD
Losartan—Decreased appetite—Pregabalin—epilepsy syndrome	3.36e-05	0.000202	CcSEcCtD
Losartan—Agitation—Topiramate—epilepsy syndrome	3.36e-05	0.000202	CcSEcCtD
Losartan—Fatigue—Pregabalin—epilepsy syndrome	3.33e-05	0.0002	CcSEcCtD
Losartan—Hypotension—Gabapentin—epilepsy syndrome	3.31e-05	0.000199	CcSEcCtD
Losartan—Nausea—Carbamazepine—epilepsy syndrome	3.31e-05	0.000199	CcSEcCtD
Losartan—Pain—Pregabalin—epilepsy syndrome	3.3e-05	0.000199	CcSEcCtD
Losartan—Constipation—Pregabalin—epilepsy syndrome	3.3e-05	0.000199	CcSEcCtD
Losartan—Malaise—Topiramate—epilepsy syndrome	3.29e-05	0.000198	CcSEcCtD
Losartan—Vertigo—Topiramate—epilepsy syndrome	3.28e-05	0.000197	CcSEcCtD
Losartan—Syncope—Topiramate—epilepsy syndrome	3.28e-05	0.000197	CcSEcCtD
Losartan—Leukopenia—Topiramate—epilepsy syndrome	3.27e-05	0.000197	CcSEcCtD
Losartan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.23e-05	0.000194	CcSEcCtD
Losartan—Palpitations—Topiramate—epilepsy syndrome	3.23e-05	0.000194	CcSEcCtD
Losartan—Loss of consciousness—Topiramate—epilepsy syndrome	3.21e-05	0.000193	CcSEcCtD
Losartan—Insomnia—Gabapentin—epilepsy syndrome	3.21e-05	0.000193	CcSEcCtD
Losartan—Nausea—Lamotrigine—epilepsy syndrome	3.2e-05	0.000192	CcSEcCtD
Losartan—Cough—Topiramate—epilepsy syndrome	3.19e-05	0.000192	CcSEcCtD
Losartan—Feeling abnormal—Pregabalin—epilepsy syndrome	3.18e-05	0.000192	CcSEcCtD
Losartan—Paraesthesia—Gabapentin—epilepsy syndrome	3.18e-05	0.000191	CcSEcCtD
Losartan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.16e-05	0.00019	CcSEcCtD
Losartan—Dyspnoea—Gabapentin—epilepsy syndrome	3.16e-05	0.00019	CcSEcCtD
Losartan—Somnolence—Gabapentin—epilepsy syndrome	3.15e-05	0.00019	CcSEcCtD
Losartan—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.15e-05	0.000189	CcSEcCtD
Losartan—Dyspepsia—Gabapentin—epilepsy syndrome	3.12e-05	0.000188	CcSEcCtD
Losartan—Arthralgia—Topiramate—epilepsy syndrome	3.11e-05	0.000187	CcSEcCtD
Losartan—Myalgia—Topiramate—epilepsy syndrome	3.11e-05	0.000187	CcSEcCtD
Losartan—Chest pain—Topiramate—epilepsy syndrome	3.11e-05	0.000187	CcSEcCtD
Losartan—Anxiety—Topiramate—epilepsy syndrome	3.1e-05	0.000186	CcSEcCtD
Losartan—Decreased appetite—Gabapentin—epilepsy syndrome	3.08e-05	0.000185	CcSEcCtD
Losartan—Discomfort—Topiramate—epilepsy syndrome	3.07e-05	0.000185	CcSEcCtD
Losartan—Urticaria—Pregabalin—epilepsy syndrome	3.07e-05	0.000185	CcSEcCtD
Losartan—Asthenia—Valproic Acid—epilepsy syndrome	3.07e-05	0.000185	CcSEcCtD
Losartan—Fatigue—Gabapentin—epilepsy syndrome	3.06e-05	0.000184	CcSEcCtD
Losartan—Abdominal pain—Pregabalin—epilepsy syndrome	3.06e-05	0.000184	CcSEcCtD
Losartan—Body temperature increased—Pregabalin—epilepsy syndrome	3.06e-05	0.000184	CcSEcCtD
Losartan—Dry mouth—Topiramate—epilepsy syndrome	3.04e-05	0.000183	CcSEcCtD
Losartan—Constipation—Gabapentin—epilepsy syndrome	3.03e-05	0.000182	CcSEcCtD
Losartan—Pain—Gabapentin—epilepsy syndrome	3.03e-05	0.000182	CcSEcCtD
Losartan—Pruritus—Valproic Acid—epilepsy syndrome	3.02e-05	0.000182	CcSEcCtD
Losartan—Confusional state—Topiramate—epilepsy syndrome	3.01e-05	0.000181	CcSEcCtD
Losartan—Oedema—Topiramate—epilepsy syndrome	2.98e-05	0.000179	CcSEcCtD
Losartan—Infection—Topiramate—epilepsy syndrome	2.96e-05	0.000178	CcSEcCtD
Losartan—Shock—Topiramate—epilepsy syndrome	2.93e-05	0.000176	CcSEcCtD
Losartan—Diarrhoea—Valproic Acid—epilepsy syndrome	2.92e-05	0.000176	CcSEcCtD
Losartan—Nervous system disorder—Topiramate—epilepsy syndrome	2.92e-05	0.000176	CcSEcCtD
Losartan—Feeling abnormal—Gabapentin—epilepsy syndrome	2.92e-05	0.000176	CcSEcCtD
Losartan—Thrombocytopenia—Topiramate—epilepsy syndrome	2.92e-05	0.000176	CcSEcCtD
Losartan—Tachycardia—Topiramate—epilepsy syndrome	2.91e-05	0.000175	CcSEcCtD
Losartan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.9e-05	0.000174	CcSEcCtD
Losartan—Hyperhidrosis—Topiramate—epilepsy syndrome	2.88e-05	0.000173	CcSEcCtD
Losartan—Hypersensitivity—Pregabalin—epilepsy syndrome	2.85e-05	0.000171	CcSEcCtD
Losartan—Anorexia—Topiramate—epilepsy syndrome	2.84e-05	0.000171	CcSEcCtD
Losartan—Dizziness—Valproic Acid—epilepsy syndrome	2.83e-05	0.00017	CcSEcCtD
Losartan—Urticaria—Gabapentin—epilepsy syndrome	2.82e-05	0.000169	CcSEcCtD
Losartan—Body temperature increased—Gabapentin—epilepsy syndrome	2.8e-05	0.000169	CcSEcCtD
Losartan—Abdominal pain—Gabapentin—epilepsy syndrome	2.8e-05	0.000169	CcSEcCtD
Losartan—Hypotension—Topiramate—epilepsy syndrome	2.79e-05	0.000168	CcSEcCtD
Losartan—Asthenia—Pregabalin—epilepsy syndrome	2.77e-05	0.000167	CcSEcCtD
Losartan—Pruritus—Pregabalin—epilepsy syndrome	2.73e-05	0.000164	CcSEcCtD
Losartan—Vomiting—Valproic Acid—epilepsy syndrome	2.72e-05	0.000164	CcSEcCtD
Losartan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.72e-05	0.000163	CcSEcCtD
Losartan—Insomnia—Topiramate—epilepsy syndrome	2.7e-05	0.000162	CcSEcCtD
Losartan—Rash—Valproic Acid—epilepsy syndrome	2.7e-05	0.000162	CcSEcCtD
Losartan—Dermatitis—Valproic Acid—epilepsy syndrome	2.69e-05	0.000162	CcSEcCtD
Losartan—Headache—Valproic Acid—epilepsy syndrome	2.68e-05	0.000161	CcSEcCtD
Losartan—Paraesthesia—Topiramate—epilepsy syndrome	2.68e-05	0.000161	CcSEcCtD
Losartan—Dyspnoea—Topiramate—epilepsy syndrome	2.66e-05	0.00016	CcSEcCtD
Losartan—Somnolence—Topiramate—epilepsy syndrome	2.65e-05	0.000159	CcSEcCtD
Losartan—Diarrhoea—Pregabalin—epilepsy syndrome	2.64e-05	0.000159	CcSEcCtD
Losartan—Dyspepsia—Topiramate—epilepsy syndrome	2.62e-05	0.000158	CcSEcCtD
Losartan—Hypersensitivity—Gabapentin—epilepsy syndrome	2.61e-05	0.000157	CcSEcCtD
Losartan—Decreased appetite—Topiramate—epilepsy syndrome	2.59e-05	0.000156	CcSEcCtD
Losartan—Fatigue—Topiramate—epilepsy syndrome	2.57e-05	0.000155	CcSEcCtD
Losartan—Dizziness—Pregabalin—epilepsy syndrome	2.56e-05	0.000154	CcSEcCtD
Losartan—Pain—Topiramate—epilepsy syndrome	2.55e-05	0.000153	CcSEcCtD
Losartan—Constipation—Topiramate—epilepsy syndrome	2.55e-05	0.000153	CcSEcCtD
Losartan—Asthenia—Gabapentin—epilepsy syndrome	2.54e-05	0.000153	CcSEcCtD
Losartan—Nausea—Valproic Acid—epilepsy syndrome	2.54e-05	0.000153	CcSEcCtD
Losartan—Pruritus—Gabapentin—epilepsy syndrome	2.51e-05	0.000151	CcSEcCtD
Losartan—Vomiting—Pregabalin—epilepsy syndrome	2.46e-05	0.000148	CcSEcCtD
Losartan—Feeling abnormal—Topiramate—epilepsy syndrome	2.46e-05	0.000148	CcSEcCtD
Losartan—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.44e-05	0.000147	CcSEcCtD
Losartan—Rash—Pregabalin—epilepsy syndrome	2.44e-05	0.000147	CcSEcCtD
Losartan—Dermatitis—Pregabalin—epilepsy syndrome	2.43e-05	0.000146	CcSEcCtD
Losartan—Diarrhoea—Gabapentin—epilepsy syndrome	2.42e-05	0.000146	CcSEcCtD
Losartan—Headache—Pregabalin—epilepsy syndrome	2.42e-05	0.000146	CcSEcCtD
Losartan—Urticaria—Topiramate—epilepsy syndrome	2.37e-05	0.000142	CcSEcCtD
Losartan—Body temperature increased—Topiramate—epilepsy syndrome	2.36e-05	0.000142	CcSEcCtD
Losartan—Abdominal pain—Topiramate—epilepsy syndrome	2.36e-05	0.000142	CcSEcCtD
Losartan—Dizziness—Gabapentin—epilepsy syndrome	2.34e-05	0.000141	CcSEcCtD
Losartan—Nausea—Pregabalin—epilepsy syndrome	2.3e-05	0.000138	CcSEcCtD
Losartan—Vomiting—Gabapentin—epilepsy syndrome	2.25e-05	0.000136	CcSEcCtD
Losartan—Rash—Gabapentin—epilepsy syndrome	2.23e-05	0.000134	CcSEcCtD
Losartan—Dermatitis—Gabapentin—epilepsy syndrome	2.23e-05	0.000134	CcSEcCtD
Losartan—Headache—Gabapentin—epilepsy syndrome	2.22e-05	0.000134	CcSEcCtD
Losartan—Hypersensitivity—Topiramate—epilepsy syndrome	2.2e-05	0.000132	CcSEcCtD
Losartan—Asthenia—Topiramate—epilepsy syndrome	2.14e-05	0.000129	CcSEcCtD
Losartan—Pruritus—Topiramate—epilepsy syndrome	2.11e-05	0.000127	CcSEcCtD
Losartan—Nausea—Gabapentin—epilepsy syndrome	2.1e-05	0.000127	CcSEcCtD
Losartan—Diarrhoea—Topiramate—epilepsy syndrome	2.04e-05	0.000123	CcSEcCtD
Losartan—Dizziness—Topiramate—epilepsy syndrome	1.97e-05	0.000119	CcSEcCtD
Losartan—Vomiting—Topiramate—epilepsy syndrome	1.9e-05	0.000114	CcSEcCtD
Losartan—Rash—Topiramate—epilepsy syndrome	1.88e-05	0.000113	CcSEcCtD
Losartan—Dermatitis—Topiramate—epilepsy syndrome	1.88e-05	0.000113	CcSEcCtD
Losartan—Headache—Topiramate—epilepsy syndrome	1.87e-05	0.000112	CcSEcCtD
Losartan—Nausea—Topiramate—epilepsy syndrome	1.77e-05	0.000107	CcSEcCtD
Losartan—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.31e-06	3.74e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—POMC—epilepsy syndrome	3.3e-06	3.72e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.28e-06	3.71e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GPX1—epilepsy syndrome	3.28e-06	3.7e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	3.27e-06	3.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.27e-06	3.69e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.27e-06	3.69e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.27e-06	3.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.25e-06	3.68e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.25e-06	3.68e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	3.23e-06	3.65e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.21e-06	3.63e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ADSL—epilepsy syndrome	3.21e-06	3.62e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ALB—epilepsy syndrome	3.19e-06	3.6e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.18e-06	3.59e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.18e-06	3.59e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	3.16e-06	3.57e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.15e-06	3.56e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GLUL—epilepsy syndrome	3.15e-06	3.55e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.14e-06	3.55e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	3.09e-06	3.49e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	3.09e-06	3.49e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.04e-06	3.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.04e-06	3.43e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.03e-06	3.42e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ALB—epilepsy syndrome	3.01e-06	3.4e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	3e-06	3.39e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	3e-06	3.39e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—POMC—epilepsy syndrome	2.97e-06	3.36e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.97e-06	3.36e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.97e-06	3.36e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.97e-06	3.35e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.97e-06	3.35e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCG2—epilepsy syndrome	2.96e-06	3.34e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.9e-06	3.27e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.89e-06	3.26e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.88e-06	3.25e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.88e-06	3.25e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AGT—epilepsy syndrome	2.87e-06	3.24e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.86e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.86e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.86e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.86e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.84e-06	3.21e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.84e-06	3.21e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—APOE—epilepsy syndrome	2.81e-06	3.18e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.8e-06	3.17e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	2.79e-06	3.16e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	2.79e-06	3.15e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.78e-06	3.14e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.76e-06	3.12e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.71e-06	3.06e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ALB—epilepsy syndrome	2.71e-06	3.06e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.71e-06	3.06e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.71e-06	3.06e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.71e-06	3.06e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.69e-06	3.04e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.68e-06	3.03e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TH—epilepsy syndrome	2.67e-06	3.02e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.65e-06	3e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AGT—epilepsy syndrome	2.63e-06	2.97e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	2.63e-06	2.97e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.61e-06	2.94e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.6e-06	2.94e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	2.59e-06	2.93e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.59e-06	2.93e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.58e-06	2.92e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.58e-06	2.92e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.58e-06	2.92e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—APOE—epilepsy syndrome	2.58e-06	2.91e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.57e-06	2.9e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.55e-06	2.88e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	2.54e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.54e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.54e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.53e-06	2.86e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.52e-06	2.85e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.51e-06	2.83e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.48e-06	2.8e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.47e-06	2.79e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.46e-06	2.78e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.46e-06	2.78e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—BCHE—epilepsy syndrome	2.45e-06	2.77e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.43e-06	2.74e-05	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.43e-06	2.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.42e-06	2.73e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—POMC—epilepsy syndrome	2.42e-06	2.73e-05	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.39e-06	2.7e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.38e-06	2.69e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	2.37e-06	2.68e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.36e-06	2.67e-05	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.36e-06	2.67e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.36e-06	2.66e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.35e-06	2.65e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.34e-06	2.65e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	2.34e-06	2.64e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.34e-06	2.64e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.33e-06	2.63e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.33e-06	2.63e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.32e-06	2.63e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.32e-06	2.62e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TH—epilepsy syndrome	2.32e-06	2.62e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.31e-06	2.61e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PLCB1—epilepsy syndrome	2.31e-06	2.61e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—TH—epilepsy syndrome	2.3e-06	2.6e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.28e-06	2.58e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	2.27e-06	2.57e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.27e-06	2.56e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.26e-06	2.56e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.23e-06	2.52e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.23e-06	2.52e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.22e-06	2.5e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	2.21e-06	2.5e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.21e-06	2.49e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ALB—epilepsy syndrome	2.2e-06	2.49e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.2e-06	2.49e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.2e-06	2.48e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.16e-06	2.45e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.16e-06	2.44e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.15e-06	2.43e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.15e-06	2.42e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	2.14e-06	2.42e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.14e-06	2.42e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.12e-06	2.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.11e-06	2.39e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.1e-06	2.37e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.07e-06	2.34e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.07e-06	2.34e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TH—epilepsy syndrome	2.07e-06	2.34e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.05e-06	2.31e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	2.04e-06	2.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.03e-06	2.3e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.02e-06	2.29e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ALB—epilepsy syndrome	2.02e-06	2.28e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TH—epilepsy syndrome	2.02e-06	2.28e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.01e-06	2.28e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—SRC—epilepsy syndrome	2.01e-06	2.28e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.01e-06	2.27e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2e-06	2.26e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2e-06	2.26e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.99e-06	2.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.99e-06	2.25e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.99e-06	2.24e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.96e-06	2.22e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.96e-06	2.21e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.96e-06	2.21e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.93e-06	2.18e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	1.93e-06	2.18e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—HMOX1—epilepsy syndrome	1.92e-06	2.17e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.91e-06	2.16e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.91e-06	2.15e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CAT—epilepsy syndrome	1.9e-06	2.14e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.89e-06	2.14e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TH—epilepsy syndrome	1.88e-06	2.13e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.86e-06	2.1e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.86e-06	2.1e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—epilepsy syndrome	1.84e-06	2.08e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.81e-06	2.05e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.81e-06	2.04e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.77e-06	2e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.75e-06	1.97e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.73e-06	1.95e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.72e-06	1.95e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.72e-06	1.94e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GPX1—epilepsy syndrome	1.71e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.71e-06	1.94e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.71e-06	1.93e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.7e-06	1.92e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.68e-06	1.9e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CAT—epilepsy syndrome	1.66e-06	1.88e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.66e-06	1.87e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.63e-06	1.85e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.62e-06	1.83e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TH—epilepsy syndrome	1.61e-06	1.82e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.6e-06	1.8e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.59e-06	1.79e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.57e-06	1.78e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.55e-06	1.76e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.55e-06	1.75e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.55e-06	1.75e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.54e-06	1.74e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.51e-06	1.71e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.51e-06	1.71e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AGT—epilepsy syndrome	1.5e-06	1.7e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.5e-06	1.7e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.48e-06	1.67e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOE—epilepsy syndrome	1.47e-06	1.66e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.47e-06	1.66e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.4e-06	1.59e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—epilepsy syndrome	1.4e-06	1.58e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.39e-06	1.58e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.35e-06	1.53e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	1.52e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.34e-06	1.51e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.33e-06	1.5e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.33e-06	1.5e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.32e-06	1.49e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.32e-06	1.49e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	1.32e-06	1.49e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AGT—epilepsy syndrome	1.32e-06	1.49e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOE—epilepsy syndrome	1.29e-06	1.46e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	1.46e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.27e-06	1.44e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	1.27e-06	1.43e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—epilepsy syndrome	1.27e-06	1.43e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.26e-06	1.42e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—epilepsy syndrome	1.25e-06	1.41e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.25e-06	1.41e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TH—epilepsy syndrome	1.24e-06	1.4e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.23e-06	1.39e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.21e-06	1.36e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.2e-06	1.36e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—epilepsy syndrome	1.19e-06	1.35e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.17e-06	1.32e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.16e-06	1.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.14e-06	1.28e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—epilepsy syndrome	1.11e-06	1.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.05e-06	1.19e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.04e-06	1.17e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.04e-06	1.17e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.04e-06	1.17e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.03e-06	1.16e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.02e-06	1.16e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.02e-06	1.15e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ALB—epilepsy syndrome	1.01e-06	1.14e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	1.14e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.96e-07	1.12e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—epilepsy syndrome	9.69e-07	1.09e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.44e-07	1.07e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.26e-07	1.05e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	9.06e-07	1.02e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	8.88e-07	1e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—epilepsy syndrome	8.85e-07	1e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	8.85e-07	9.99e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	8.26e-07	9.34e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.12e-07	9.17e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ALB—epilepsy syndrome	8.07e-07	9.12e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.95e-07	8.99e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	7.06e-07	7.98e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.83e-07	7.72e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.23e-07	7.04e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.89e-07	6.66e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.45e-07	6.16e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—epilepsy syndrome	5.1e-07	5.77e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—epilepsy syndrome	5.07e-07	5.73e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.55e-07	5.15e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.45e-07	5.02e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.15e-07	4.69e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3.55e-07	4.01e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.74e-07	3.09e-06	CbGpPWpGaD
